← Back to Nuqta Atlas
Editorially curated · sa-genesis-masld
Genomics and Environmental Noninvasive Evaluation for Saudi Intrahepatic Steatosis
Combines lifestyle and environmental exposure data, FibroScan phenotyping, genomics and other omics to define MASLD risk and progression in Saudis.
01 / Project overview
What the record establishes.
- Geographic scope
- Saudi Arabia; KFSHRC and Ministry of Defense Health Services
- Project type
- National longitudinal multi-omics cohort
- Research domain
- Metabolic dysfunction-associated steatotic liver disease
- Years
- Not stated
- Lifecycle status
- active
- Status basis
- The current official project page reports that approximately 3,000 participants have already been enrolled and describes continuing substudies.
- Status evidence date
- 2026-08-15
- Scale
- Approximately 3,000 enrolled; described by KFSHRC as the largest MASLD study in the Middle East.
02 / Organizations and population
Who and what the project connects.
- Lead organizations
- King Faisal Specialist Hospital & Research Centre (KFSHRC)
- Partner organizations
- Ministry of Defense Health Services
- Organism / population
- Saudi adults with or at risk of MASLD
03 / Data and access
What exists and how it can be reached.
Data types
- genomics
- metabolomics
- proteomics
- lipidomics
- FibroScan
- clinical and lifestyle data
Data access
Not stated; cohort resource/controlled
Identifiers
No public accession or identifier is listed for this record.
04 / Evidence and provenance
Why the record is included.
Inclusion basis
Named, already-enrolled multi-omics cohort of national relevance and major scale.
Editorial note
The official page does not report a launch year or public accession.
Sources
- primary record source Verified 2026-08-15
Release v0.2.0